使用雷加代诺森应对压力第一通透输液心脏MRI成像:如何,何时,为什么?
Bon-Marin Mulot1, Hajer Chennoufi1, Matthieu Demeyere1
1Department of Radiology, University Hospital of Rouen 76000 Rouen, France.
雷加迪诺松为压力心脏磁共振成像 (MRI) 提供了一种安全有效的替代腺. 这种腺A2A受体激动剂为冠状动脉疾病评估提供了宝贵的诊断和预后信息.
科学领域:
- 心脏病学 心脏病学
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏MRI对于诊断冠状动脉疾病,评估心肌活力和指导重血管化决策至关重要.
- 氨酸是压力心脏MRI的标准血管扩展剂,但其使用可能受到副作用和管理复杂性的限制.
- 雷加迪诺松是一种腺A2A受体激动剂,具有有利的药理动力学和安全性概况,是有前途的替代品.
研究的目的:
- 审查雷加代诺松在压力心脏MRI中的特性,安全性和应用.
- 为了比较regadenoson与adenosine作为心脏MRI的血管扩展剂.
- 讨论心脏MRI中对regadenoson的临床实用性和补偿考虑.
主要方法:
- 综述关于雷加代诺松和心脏MRI的现有文献.
- 对regadenoson的药理动力学和药理动力学特性进行分析.
- 讨论临床试验数据和安全概况.
主要成果:
- 雷加代诺松显示出迅速开始和抵消作用,促进压力输液成像.
- 与腺相比,它具有有利的安全性,对抗症候较少.
- 雷加登诺森在检测显著的冠状动脉疾病方面提供了与腺相比较的诊断准确性.
结论:
- 雷加迪诺森是适合和有效的替代阿德诺辛用于血管扩张剂诱导的应激心脏MRI.
- 它的易用性和安全性提升了它在临床实践中的实用性.
- 进一步评估其长期预测价值和更广泛的退款是合理的.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
相关概念视频
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiac Catheterization I: Pre-Procedure Overview
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Acute Coronary Syndrome III: Diagnostic Studies
